Loading...
Detection of Minimal Residual Disease by Flow Cytometry for Patients with Multiple Myeloma Submitted to Autologous Hematopoietic Stem Cell Transplantation
The treatment strategy in multiple myeloma (MM) is to get complete remission followed by high-dose chemotherapy and autologous Hematopoietic Stem Cell Transplantation (HSCT). Neoplastic Plasma Cells (NPCs) are CD45(−/dim), CD38(+high), CD138(+), CD19(−), and CD56(+high) in most cases. The descripti...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Hindawi Publishing Corporation
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3705753/ https://ncbi.nlm.nih.gov/pubmed/23864957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/847672 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|